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Why digital medicine depends on interoperability
Moritz Lehne 1, Julian Sass 1, Andrea Essenwanger 1, Josef Schepers 1 and Sylvia Thun1,2,3
Digital data are anticipated to transform medicine. However, most of today’s medical data lack interoperability: hidden in
isolated databases, incompatible systems and proprietary software, the data are difﬁcult to exchange, analyze, and interpret.
This slows down medical progress, as technologies that rely on these data – artiﬁcial intelligence, big data or mobile
applications – cannot be used to their full potential. In this article, we argue that interoperability is a prerequisite for the digital
innovations envisioned for future medicine. We focus on four areas where interoperable data and IT systems are particularly
important: (1) artiﬁcial intelligence and big data; (2) medical communication; (3) research; and (4) international cooperation. We
discuss how interoperability can facilitate digital transformation in these areas to improve the health and well-being of patients
worldwide.
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INTRODUCTION
The digitalization of medicine promises great advances for global
health. Electronic medical records, mobile health apps, medical
imaging, low-cost gene sequencing as well as new sensors and
wearable devices provide an ever-increasing ﬂow of digital health
data. Combined with artiﬁcial intelligence, cloud computing and
big data analytics, this wealth of data holds huge potential for
healthcare and can improve the lives of millions of patients
worldwide – with better diagnostics, personalized treatments, and
early disease prevention.1–6
But medical data are only useful if they can be turned into
meaningful information. This requires high-quality datasets,
seamless communication across IT systems and standard data
formats that can be processed by humans and machines. Judged
by these criteria, however, large parts of today’s medical data are
virtually useless: Hidden in isolated data silos and incompatible
systems, the data are difﬁcult to exchange, process and interpret.
In fact, the current medical landscape seems less characterized by
“big data” but rather by a large number of disconnected small
data. These are suboptimal conditions for the data-driven
technologies anticipated to drive medical innovation. Uncovering
the full potential of digital medicine requires an interconnected
data infrastructure with fast, reliable and secure interfaces,
international standards for data exchange as well as medical
terminologies that deﬁne unambiguous vocabularies for the
communication of medical information. In short: Digital health
depends on interoperability.
The aim of this article is to show why interoperability is so
important for achieving the full potential of digitalization in
healthcare and medicine. Although the importance of interoper-
able health IT systems is increasingly acknowledged,7–9 awareness
of this topic is still relatively low among healthcare professionals –
especially compared with topics such as artiﬁcial intelligence, big
data or mobile technologies, which are generally seen as the main
drivers of digital health innovation.6,10–13 Accordingly, progress in
health interoperability is slow.14 Here, we argue that
interoperability is indispensable for advances in digital health
and that it is, in fact, a prerequisite for most of the innovations
envisioned for future medicine.
Our article starts with an overview of interoperability and its
different levels: technical, syntactic, semantic, and organizational.
It then shows how interoperability can improve medicine,
focusing on four areas that especially beneﬁt from (and some-
times crucially depend on) interoperable health IT systems: (1)
artiﬁcial intelligence and big data; (2) medical communication; (3)
research; and (4) international cooperation (Fig. 1). We chose these
four areas because they illustrate particularly well how interoper-
ability can facilitate digital transformation and improve medicine
and healthcare (however, the areas are not mutually exclusive,
and advancing, for example, medical communication can also
improve international cooperation). Note that our views are
shaped by our German/European perspective. However, we
discuss points general enough to be relevant for international
readers. Also note that, though giving some examples of speciﬁc
health IT standards and medical terminologies that can improve
interoperability, this article does not aim to provide detailed
technical discussions of speciﬁc standards or terminologies (this
information can be found elsewhere15,16).
INTEROPERABILITY
Interoperability can be broadly deﬁned as “the ability of two or
more systems or components to exchange information and to use
the information that has been exchanged”.17 Most deﬁnitions
further distinguish between different components, layers or levels
of interoperability.15,16 Although these components can slightly
differ across deﬁnitions, they generally follow a distinction
between lower-level technical components and higher-level
organizational components. In line with this conceptualization,
this section gives a brief overview of technical, syntactic, semantic
and organizational aspects of interoperability.
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Technical interoperability
Technical interoperability ensures basic data exchange capabilities
between systems (for example, moving data from a USB stick to a
computer). This requires communication channels and protocols
for data transmission. With today’s digital networks and commu-
nication protocols, achieving technical interoperability is usually
relatively straightforward. However, moving data from A to B is
not enough. To process the data and extract meaningful
information, syntactic and semantic interoperability is needed.
Syntactic interoperability
Syntactic interoperability speciﬁes the format and structure of the
data (for example, in an XML document). The structured exchange
of health data is supported by international standards develop-
ment organizations (SDOs) such as Health Level Seven Interna-
tional (HL7) or Integrating the Healthcare Enterprise (IHE), which
specify health IT standards and their use across systems. An
emerging standard for the communication of health data is, for
example, HL7’s Fast Healthcare Interoperability Resources (FHIR),
which deﬁnes around 140 common healthcare concepts, so-called
resources, which can be accessed and exchanged using modern
web technologies.18 FHIR is increasingly adopted by the health
industry, as it lends itself to the development of mobile health
apps that run on different IT systems.19 Another initiative aiming
to improve the structured exchange of health data is openEHR.
OpenEHR allows medical professionals and health IT experts to
deﬁne clinical content using so-called archetypes, speciﬁcations of
clinical concepts based on an underlying reference model.20
OpenEHR includes a portable language for querying, the
Archetype Querying Language (AQL), as well as tools for deﬁning
and publishing the archetypes.
Semantic interoperability
While standards such as FHIR and openEHR already deﬁne basic
semantics of health data, semantic interoperability is really the
domain of medical terminologies, nomenclatures, and ontologies.
They ensure that the meaning of medical concepts can be shared
across systems, thus providing a digital “lingua franca”, a common
language for medical terms that is, ideally, understandable to
humans and machines worldwide. With more than 340,000
medical concepts (including, for example, clinical ﬁndings,
procedures, substances, organisms, or body structures), the
terminology SNOMED CT seems particularly well-suited as a
general-purpose language for advancing semantic interoperability
in medicine and healthcare.21 It can be complemented by more
domain-speciﬁc terminologies such as, for example, Logical
Observation Identiﬁers Names and Codes (LOINC) for laboratory
observations,22 the Identiﬁcation of Medicinal Products (IDMP) for
medicines,23 the nomenclature of the HUGO Gene Nomenclature
Committee (HGNC) for genes24 or the Human Phenotype
Ontology (HPO) for phenotypic abnormalities.25 Combined with
the standards discussed above, the use of these terminologies can
ensure that health data have a clear structure and unambiguous
semantics.
Organizational interoperability
At the highest layer, interoperability also involves organizations,
legislations and policies. Exchanging data across health IT systems
is not an end in itself but should, ultimately, help healthcare
professionals to work more efﬁciently and improve patients’
health. This requires common business processes and workﬂows
that enable a seamless provision of healthcare across institutions.
As different stakeholders in healthcare have different interests
(and these interests do not always aim to maximize interoper-
ability), this also requires policies that provide incentives for
interoperable data exchange and, if necessary, enforce interoper-
ability via legal regulations.
HOW INTEROPERABILITY CAN IMPROVE MEDICINE
Interoperability for artiﬁcial intelligence and big data
Digital technologies such as artiﬁcial intelligence (AI) and the
large-scale analytics subsumed under the term “big data” are
increasingly changing medicine and healthcare.6,10,12 These
technologies rely on growing volumes of digital medical data.
Therefore, to use AI algorithms and big data analytics to their full
capacity and feed them with maximum input, processing
information from different systems and across institutional
boundaries is crucial. A comprehensive analysis of a patient’s
health data could, for example, require information from general
practitioners, hospitals, laboratories, mobile health apps, and
wearable sensors. Similarly, multiple data sources are often
Fig. 1 Overview showing how interoperability can improve medicine in the areas of artiﬁcial intelligence (AI) and big data, medical
communication, research, and international cooperation
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necessary when data are scarce, for example, in the areas of rare
diseases, precision medicine, or pharmacogenomics: tailoring
treatments and drugs to increasingly smaller subpopulations of
patients requires a large pool of comparable data, making it
necessary to exchange information across systems, institutions,
and countries.
Unfortunately, today’s digital health infrastructure makes large-
scale data processing across IT systems still unnecessarily difﬁcult.
Current health IT systems operate with a wide variety of data
formats, custom speciﬁcations and ambiguous semantics. This
situation is exacerbated by the trend to store increasing amounts
of unstructured data in non-relational databases and so-called
data lakes.26 Although these unstructured data are, arguably,
better than no data – and modern algorithms can partly extract
useful information even from unstructured data – they are difﬁcult
to process. As a consequence, time-consuming data cleaning and
pre-processing procedures are usually necessary before analysis.
Moreover, running algorithms on unstructured, non-
standardized data can introduce errors that distort analysis results.
An AI algorithm programmed to identify, for example, diabetes
patients from unstructured text could erroneously select patients
with a family history of diabetes, not actual diabetes (not to
mention the different types and subgroups of diabetes that could
easily be confused). Such errors are difﬁcult to detect in large
datasets because the sheer volume of the data makes it difﬁcult to
anticipate, detect and correct all possible errors. This can
introduce systematic biases, which compromise the validity of
analysis results and which will eventually undermine trust in
digital health technologies. This problem becomes even more
relevant when considering the rise of artiﬁcial neural networks
and deep learning algorithms. Although these algorithms can
increasingly compete with (and even outperform) human
experts,27–29 the mechanisms that drive their decisions usually
remain hidden within the network. As these methods are
essentially “black boxes” for human users, it is important that
their calculations are based on a solid foundation. This requires
data with a clear structure and unambiguous semantics. Other-
wise, modern AI algorithms could do more harm than good – not
because their calculations are wrong but because they rely on
questionable input.
To avoid these pitfalls and provide AI algorithms and big data
technologies with usable input, interoperability of health data is
essential. The largest barrier for applying AI and big data to
medicine is, arguably, not a lack of algorithms but a lack of
suitable data for developing AI and big data applications. Using
the international standards and terminologies mentioned pre-
viously can therefore help to provide algorithms with structured
and meaningful data and foster the use of AI and big data in
medicine.
Interoperability for medical communication
Digital medicine does not always require sophisticated analytics or
complex AI algorithms. In many cases, simply making the right
information available to the right person at the right time can
signiﬁcantly improve patient care. Often, important parts of
medical information are lost as patients move through the
healthcare system. For example, if a patient is rehospitalized,
relevant information from previous visits to other hospitals may
not be available (in Germany, medical information can sometimes
not even be shared across different departments of the same
hospital due to data protection regulations). This leads to
inefﬁciencies in care and sometimes poses serious risks for
patients (for example, if a lack of communication results in adverse
drug interactions). Giving healthcare providers the necessary
information about their patients can help to avoid such
inefﬁciencies and improve the quality of care.
Promoting the use of interoperable electronic health records
(EHRs) is particularly important in this context. Too often, EHRs are
disconnected, proprietary solutions buried in systems that do not
talk to each other. The use of international standards and
terminologies can make EHRs interoperable, enabling the reliable
communication of medical information. Existing speciﬁcations for
patient summary data such as the International Patient Summary
(IPS) developed by HL7 and the European Committee for
Standardization (CEN)30 can further help clinicians to access
relevant, accurate, and up-to-date medical information about their
patients.
Importantly, by making relevant health information easily
accessible, interoperable health IT systems should also make lives
easier for physicians and other healthcare professionals. The rise
of digital health technologies often raises concerns that physicians
have to spend more time with documentation and data entry and
less time with their patients. But interoperable EHRs can reduce
the documentation burden (for example, by avoiding repeated
entry of data) and simplify cumbersome information retrieval
processes. This can enable physicians to focus on their patients
and provide optimal care.
On the other end of the spectrum, interoperable EHRs can also
help patients to manage their own health more actively. Currently,
much of the information that drives providers’ decisions about
treatments is not easily accessible to the patients themselves,
making them inactive bystanders in the treatment process. If
patients are given better access to their health data (combining,
for example, information about prescriptions, treatments and data
from personal health apps), they can take more control of their
health. This in itself can have positive health effects, as patients
turn from helpless recipients of healthcare to active managers of
their health and well-being.
Interoperability for research
Apart from improving health at the point of care, interoperability
can also advance medical research. This is particularly true for the
ﬁeld of real-world evidence: Using interoperable formats for real-
world data (that is, data routinely collected in medical care or,
increasingly, via mobile apps in patients’ everyday lives) opens up
various opportunities for researchers. First, if real-world data are
interoperable, they can be used for large-scale observational
studies at regional, national or global levels. Such studies can
address epidemiological questions and public health concerns,
providing, for example, up-to-date insights into prevalence and
incidence of disease, typical treatment pathways of patients or
gaps in care. Second, real-world data are a treasure trove for the AI
and machine learning methods discussed above. Being able to
ﬁnd patterns and correlations in high-dimensional datasets, these
methods can help researchers to identify interesting new research
hypotheses, which can subsequently be investigated more closely
in controlled clinical trials (these controlled trials will remain
important to rule out spurious correlations and identify causal
relationships).
More generally, if health data are structured according to
international standards, data are much easier to analyze, and
efforts needed for data cleaning and pre-processing are reduced.
This can speed up the research process and also makes the
development of analysis scripts more ﬂexible: If researchers and
data scientists know that data will conform to certain formats and
semantics, analyses no longer need to be programmed with direct
access to the data. Instead, analyses can be developed remotely
and later be transferred to the data site to compute results. This
can unlock data sources that would otherwise not be easily
accessible (due to, for example, strict data protection regulations).
It can also improve research quality because analyses can be
programmed by experts worldwide, not only by those who have
direct access to the data (and who happen to know their
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idiosyncratic structure). Similarly, interoperable data can ensure
that one analysis can be done across many different data sources,
covering data from different institutions or countries. This enables
research in areas where data are sparse and therefore need to be
pooled across different institutions (see next section).
In sum, interoperability can generate new medical insights,
making it possible to analyze existing data sources more
efﬁciently. This can advance translational medicine and help to
move research discoveries swiftly from the laboratory to the point
of care. At a larger scale, it can drive evidence-based practices in
medicine and accelerate their implementation into public health
policies.
Interoperability for international cooperation
Interoperable interfaces and standard terminologies make health
data exchangeable and comparable across systems, institutions
and countries. This has obvious beneﬁts for cross-institutional and
international cooperation. As mentioned previously, exchanging
health data across different IT systems is especially important
when data are scarce or when very large datasets are needed,
such as in research on rare diseases, precision medicine or drug
development. In the case of rare diseases, for example, the
number of patients is often so small that even large health
institutions may have access to only a handful of cases of a given
disease (sometimes only a single patient). To get a better
understanding of these diseases and improve diagnosis and
treatment, data exchange across institutions is therefore crucial.
National and international networks like the Undiagnosed
Diseases Network (UDN)31 in the US or the European Reference
Networks (ERNs)32 already aim to improve collaboration between
clinicians treating rare diseases. The adoption of standard data
formats and terminologies such as the Orphanet rare disease
nomenclature33 or the previously mentioned HPO for phenotypic
abnormalities25 can help to coordinate international efforts to
optimize research and care in this area.
Exchanging health data internationally is also essential for
tackling global health issues more effectively. Arguably the most
serious public health risk – or, for that matter, the most serious risk
for humanity in general – is a global pandemic.34 Last year’s
centenary of the 1918 inﬂuenza epidemic should remind us of the
potentially devastating consequences of such pandemics, with
levels of human suffering and death only comparable to the
deadliest wars (the 1918 inﬂuenza epidemic, or “Spanish ﬂu”, has
been estimated to have killed at least 50 million people
worldwide).35 In today’s highly connected world, a dangerous
epidemic could spread within hours from almost anywhere in the
world to Berlin, Beijing or Buenos Aires, killing tens of millions of
people within a few months.36 But the same global connectedness
by which epidemics can spread rapidly around the globe can also
help us to control them. If health data are interoperable so that
information can be easily exchanged across borders and
organizations, effective surveillance systems can be established
that allow for an accurate tracking of global disease movements.
Outbreaks can then be detected early and further spread
prevented.
Importantly, interoperable health IT systems not only facilitate
the exchange of data but also the exchange of algorithms,
applications and technologies. If organizations standardize their
data, cutting-edge health applications developed for these
standardized data could be made available to patients and
physicians worldwide. The wide use of smartphones and mobile
apps can further contribute to the dissemination of digital health
technology. This can aid the “democratization” of medicine,
making health technologies globally accessible and improving
healthcare in underprivileged regions of the world.37,38
2019 has seen the ﬁrst exchange of common data models
between European countries (an electronic prescription and a
digital patient summary).39,40 This demonstrates that cross-border
exchange of interoperable health data is attainable, even though
it is still a long way to a global infrastructure for interoperable data
exchange. But gradually expanding the reach of these and other,
more extended data models will eventually advance the interna-
tional exchange of health data to provide seamless, cross-border
care to patients.
CONCLUSION AND OUTLOOK
Digital medicine depends on interoperable and standardized data.
In this article, we discussed how interoperable health data can
help to realize the full potential of AI and big data, improve the
communication of medical information, make medical research
more efﬁcient and foster international cooperation. As interoper-
ability requires the collaborative efforts of healthcare profes-
sionals, researchers, IT experts, data engineers, and politicians, it is
important to make interoperability a prominent topic in medicine
and healthcare. Eventually, efforts to improve interoperability will
pay huge dividends: With international standards and medical
terminologies, interoperability can pave the way for an inter-
connected digital health infrastructure that overcomes barriers
between individuals, organizations and countries. This will make it
possible to turn digital medical data into meaningful information
and improve the health and well-being of patients worldwide.
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